Biggest News Aggregation in the World
📰 Aldx News

Page 5 - Aldx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.

Aldeyra Therapeutics (NASDAQ:ALDX) Trading Up 6.4%

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating)’s stock price traded up 6.4% on Monday . The stock traded as high as $10.14 and last traded at $10.14. 368,965 shares changed hands during trading, a decline of 47% from the average session volume of 696,185 shares. The stock had previously closed at $9.53. Analyst Upgrades and […]
Knoll Capital Management Aldeyra Therapeutics Inc Jump Financial Tang Capital Management Cubist Systematic Strategies Aldeyra Therapeutics Company Profile
Source: wkrb13.com

Aldeyra Therapeutics (NASDAQ:ALDX) Share Price Crosses Above Fifty Day Moving Average of $7.43

Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.43 and traded as high as $9.87. Aldeyra Therapeutics shares last traded at $9.73, with a volume of 832,726 shares trading hands. Analysts Set New […]
Aldeyra Therapeutics Inc Dorsey Wright Associates Tower Research Capital Josephp Lucia Associates Barclays Plc Magnus Financial Group
Source: wkrb13.com

Aldeyra Therapeutics (NASDAQ:ALDX) Sees Unusually-High Trading Volume

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) saw unusually-strong trading volume on Monday . Approximately 712,812 shares changed hands during trading, an increase of 44% from the previous session’s volume of 493,919 shares.The stock last traded at $8.61 and had previously closed at $9.03. Analyst Upgrades and Downgrades A number of research analysts have issued […]
Josephp Lucia Associates Aldeyra Therapeutics Inc Dorsey Wright Associates Barclays Plc Aldeyra Therapeutics Company Profile Magnus Financial Group
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Analysts Set Expectations for Aldeyra Therapeutics, Inc's Q1 2023 Earnings (NASDAQ:ALDX)

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) – Oppenheimer issued their Q1 2023 EPS estimates for shares of Aldeyra Therapeutics in a report issued on Thursday, March 9th. Oppenheimer analyst J. Kim expects that the biotechnology company will post earnings of ($0.26) per share for the quarter. The consensus estimate for Aldeyra Therapeutics’ current full-year […]
Woodstock Corp International Assets Investment Management Virtu Financial Aldeyra Therapeutics Inc Knoll Capital Management Jump Financial

Analysts Expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Will Announce Earnings of -$0.32 Per Share

Wall Street analysts expect Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) to report earnings of ($0.32) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Aldeyra Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.29) and the lowest estimate coming in at ($0.36). Aldeyra Therapeutics […]
Berenberg Bank Verition Fund Management Goldman Sachs Group Inc Zacks Investment Research Aldeyra Therapeutics Inc Wall Street

Kestra Advisory Services LLC Has $67,000 Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX)

Kestra Advisory Services LLC increased its stake in shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) by 33.4% during the 4th quarter, Holdings Channel reports. The fund owned 16,809 shares of the biotechnology company’s stock after acquiring an additional 4,212 shares during the period. Kestra Advisory Services LLC’s holdings in Aldeyra Therapeutics were worth […]
Thomson Reuter Eagle Asset Management Inc Aldeyra Therapeutics Company Profile Get Rating Sg Americas Securities Jetstream Capital International Assets Investment Management

Aldeyra Therapeutics (NASDAQ:ALDX) Announces Quarterly Earnings Results

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) posted its earnings results on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.01, MarketWatch Earnings reports. During the same quarter last year, the firm earned ($0.35) earnings per share. ALDX stock traded up $0.19 during mid-day […]
United States Morgan Stanley Wells Fargo Company America Corp Invesco Ltd Aldeyra Therapeutics

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science